Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market

ORION CORPORATION PRESS RELEASE 30 JUNE 2026 at 8.00 EEST

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.